Tapiola T - Search Results

1

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T. Tapiola T, et al. Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596. Arch Neurol. 2009. PMID: 19273758

2

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO. Leinonen V, et al. Among authors: tapiola t. Arch Neurol. 2008 Oct;65(10):1304-9. doi: 10.1001/archneur.65.10.noc80013. Epub 2008 Aug 11. Arch Neurol. 2008. PMID: 18695050

3

CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.

Tapiola T, Lehtovirta M, Ramberg J, Helisalmi S, Linnaranta K, Riekkinen P Sr, Soininen H. Tapiola T, et al. Neurology. 1998 Jan;50(1):169-74. doi: 10.1212/wnl.50.1.169. Neurology. 1998. PMID: 9443475

4

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.

Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, Alafuzoff I, Riekkinen P Sr, Soininen H. Tapiola T, et al. Neuroreport. 1997 Dec 22;8(18):3961-3. doi: 10.1097/00001756-199712220-00022. Neuroreport. 1997. PMID: 9462474 Clinical Trial.

5

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

Tapiola T, Pirttilä T, Mikkonen M, Mehta PD, Alafuzoff I, Koivisto K, Soininen H. Tapiola T, et al. Neurosci Lett. 2000 Feb 18;280(2):119-22. doi: 10.1016/s0304-3940(00)00767-9. Neurosci Lett. 2000. PMID: 10686392

6

Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease.

Tapiola T, Pirttilä T, Mehta PD, Alafuzofff I, Lehtovirta M, Soininen H. Tapiola T, et al. Neurobiol Aging. 2000 Sep-Oct;21(5):735-40. doi: 10.1016/s0197-4580(00)00164-0. Neurobiol Aging. 2000. PMID: 11016543

7

CSF tau and Abeta42 levels in patients with Down's syndrome.

Tapiola T, Soininen H, Pirttilä T. Tapiola T, et al. Neurology. 2001 Apr 10;56(7):979-80. doi: 10.1212/wnl.56.7.979. Neurology. 2001. PMID: 11294944 No abstract available.

8

Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.

Lamsa R, Helisalmi S, Herukka SK, Tapiola T, Pirttila T, Vepsalainen S, Hiltunen M, Soininen H. Lamsa R, et al. Among authors: tapiola t. Dement Geriatr Cogn Disord. 2007;24(2):146-50. doi: 10.1159/000105164. Epub 2007 Jul 5. Dement Geriatr Cogn Disord. 2007. PMID: 17622762

9

Abeta levels in serum, CSF and brain, and cognitive deficits in APP + PS1 transgenic mice.

Liu L, Tapiola T, Herukka SK, Heikkilä M, Tanila H. Liu L, et al. Among authors: tapiola t. Neuroreport. 2003 Jan 20;14(1):163-6. doi: 10.1097/00001756-200301200-00030. Neuroreport. 2003. PMID: 12544850

10

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H. Buerger K, et al. Among authors: tapiola t. Arch Neurol. 2002 Aug;59(8):1267-72. doi: 10.1001/archneur.59.8.1267. Arch Neurol. 2002. PMID: 12164722 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page